Lymphoma Patients Highly Vulnerable To COVID

    Every year on 15th September, World Lymphoma Awareness Day is held around the world to raise awareness of lymphoma, an uncommon form of cancer that develops in the lymphatic system.

    Lymphoma is potentially a life-threatening disease that is increasing in incidence over time. So, it is a global initiative to raise public awareness in order to let people know about the signs and symptoms of lymphoma. This helps the public around the world in recognizing its symptoms leading to earlier diagnosis and timely treatment.

    On the eve of World Lymphoma Awareness Day, here is an article by Dr. Bhanu Prakash, Consultant Medical, haemato-oncology at Medicover Hospitals about the risk of developing COVID in lymphoma patients

    Patients suffering from lymphoma, and having low levels of immunity, are considered among the groups at high risk of contracting Covid-19, and even falling prey to the deadly virus, say doctors.

    No study has exactly pinpointed the exact adverse impact of the Covid-19 virus on lymphoma/cancer patients but it is widely accepted that they are among high-risk groups.

    On the eve of World Lymphoma Awareness Day, the focus is on means to protect those who are at risk of infections, and its adverse effects, medical experts say.

    Patients who undergo/undergoing cancer treatment have their immune system compromised, making them more vulnerable to infections, including that of corona virus. And those with hematological malignancies such as acute myeloid leukemia (AML), lymphoma, and myeloma may be particularly vulnerable as these cancers weaken the immune system.

    “Immune system of an individual weakens when he/she is put through chemotherapy or immunotherapy or radiation therapy and increases the risk of patients undergoing these treatments to get infected with SARS-CoV-2/Covid-19 virus. Even patients who are not receiving active cancer treatment must stay cautious as the effects of past therapy are usually long-lasting,” said Dr. Bhanu Prakash, Consultant Medical, haemato-oncology, Medicover Hospitals.

       MD (Manipal), DM (JIPMER)
      Consultant Medical, Hemoto Oncology
       Experience:  4+ years
       Medicover Hospitals, HITEC City

       Consultation fee:  500
       Ratings:  4.5
       Timings:  10:00 AM – 3:30 PM
       Available Days:  M | T | W | T | F | S